Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Colorcon
Medtronic
AstraZeneca
Julphar
McKesson
Fuji
Daiichi Sankyo

Generated: December 13, 2018

DrugPatentWatch Database Preview

Litigation Details for Louisiana Wholesale Drug Company Inc. v. Abbott Laboratories (D. Del. 2005)

« Back to Dashboard

Louisiana Wholesale Drug Company Inc. v. Abbott Laboratories (D. Del. 2005)

Docket ➤ Try a Free Trial Date Filed 2005-05-27
Court District Court, D. Delaware Date Terminated 2009-04-23
Cause 15:2 Antitrust Litigation Assigned To Sue Lewis Robinson
Jury Demand Plaintiff Referred To
Parties ABBOTT LABORATORIES; ALL PARTIES; ALL PLAINTIFFS; AMERICAN SALES COMPANY INC.; CVS PHARMACY INC.; ECKERD CORPORATION; FOURNIER INDUSTRIE ET SANTE'; IMPAX LABORATORIES INC.; KROGER CO.; LABORATORIES FOURNIER S.A.; LOUISIANA WHOLESALE DRUG COMPANY INC.; MAXI DRUG INC.; MEIJER DISTRIBUTION INC.; MEIJER INC.; PLAINTIFFS; RITE AID CORPORATION; RITE AID HDQTRS CORP.; ROCHESTER DRUG CO-OPERATIVE INC.; WALGREEN CO.
Patents 4,026,894; 4,251,532; 4,800,079; 4,895,726; 5,338,732; 5,504,207; 5,641,803; 5,670,537; 6,074,670; 6,277,405; 6,589,552; 6,652,881; 7,037,529; 7,041,319
Attorneys Adam M. Steinfeld; All Plaintiffs; Anne Shea Gaza; Bradley J. Demuth; Daniel Berger; David P. Germaine; David P. Smith; David S. King; Elizabeth M. McGeever; Eric L. Cramer; Frederick L. Cottrell , III; Impax Laboratories Inc.; James Walter Parrett , Jr.; Jeffrey I. Weinberger; Jeffrey S. Goddess; Jessica Zeldin; John D. Radice; Joseph M. Vanek; Joseph T. Lukens; Linda P. Nussbaum; Maria M. DiMoscato; Mary B. Graham; Michael F. Heim; Neill W. Clark; Peter Kohn; Plaintiffs; Richard J. Kilsheimer; Robert N. Kaplan; Russell A. Chorush; Scott E. Perwin; Sonia K. Pfaffenroth; Steig D. Olson; Steve D. Shadowen; Stuart N. Senator
Firms Morris, Nichols, Arsht & Tunnell; Prickett, Jones & Elliott, P.A.; Rosenthal, Monhait & Goddess, P.A.
Link to Docket External link to docket
Small Molecule Drugs cited in Louisiana Wholesale Drug Company Inc. v. Abbott Laboratories
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , ➤ Try a Free Trial , and ➤ Try a Free Trial .

Details for Louisiana Wholesale Drug Company Inc. v. Abbott Laboratories (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2005-05-27 1 Complaint s application for U.S. Patent 4,895,726 (the “‘726 patent”). In its ‘726 Patent, Fournier claims a dosage…for U.S. Patent 6,589,522 (the “‘552 patent”) and one for U.S. Patent 6,652,881 (the “‘881 patent”), shortly…that the new patents claim either the approved drug (for compound patents) or that the patents claim the …, U.S. Patent No. 6,074,670 (the “‘670 patent”), which issued on June 13, 2000, and U.S. Patent No. 6,…alleged infringement of the ‘726 Patent, the ‘670 patent, and the ‘405 patent; the second complaint was filed External link to document
2006-05-08 108 Exhibit G - END fraudulently obtained U.S. patent No. 5,641,803 (the “ '803 natent”l and U.S. patent No. 5,670.537 (the “…commenced sham patent infringement litigation with respect to the '537 patent and '803 patent against…U.S. patent No. 6,090,331 (the “ '331 patent”) in the Orange Book and to commence sham patent infringement…atent” , (ii) wrongfully listed the ’803 patent and '537 patent in the Food and Drug Administration'…infringement litigation with respect to the '33] patent against manufacturers of generic substitutes of External link to document
2006-05-15 110 Exhibit ), of Bristol-Myers' U.S. Patent No. 5,338,732 (“the '732 patent”) for megestrol acetate oral …unenforceability of U.S. Patent Nos. 6,028 065 (“the '065 patent”), 6,268,356 (“the '356 patent”), 6,593,3]…Par Patents were procured by fraud on the U.S. Patent and Trademark Office (“PTO”) and the patents would…the '065 patent in light of th_e '732 patent, Par argued that the '732 patent discloses that… '356 patent by asserting the relatedness of the '356 patent and the '065 patent, making further External link to document
2005-09-29 32 Redacted Document Foumier’s patent application as U.S. Patent No. 4,895,726 (the “‘726 patent”). The ‘726 patent is titled… U.S. Patent 6,589,552 (the “‘552 patent”) and one for U.S. Patent 6,652,881 (the “‘881 patent”), shortly…are sometimes protected by a patent or patents, which provide the patent owner with the exclusive right… of the patent or patents involved, plus any extensions. Under 21 U.S.C. § 355(b)(1), a patent holder …filed patent information with the FDA (a “paragraph I certification”); (2) the patent or patents have External link to document
Date Filed Document No. Description Snippet Link To Document

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Moodys
AstraZeneca
UBS
Express Scripts
Queensland Health
QuintilesIMS
Mallinckrodt
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.